• -
38 Results
This photo depicts many stem cells.
Can We Do That Here? An Analysis of U.S. Federal and State Policies Guiding Human Embryo and Embryoid Research
Scientists and members of the public exploring the controversial area of U.S. human embryo and embryoid research will find a complex and sometimes bewildering assortment of federal and state laws. The authors recommend additional guidance, but note slow progress in the development of embryo research policy.
Kirstin R.W. Matthews, Daniel Moralí June 28, 2022
Embryo
Emerging Human Embryo Research Technologies, the 14-day Rule, and the Special Status of the Embryo
The authors examine a proposal for new human embryo and embryoid guidelines, writing that before conducting any research beyond day 14, scientists must develop clear, thoughtful and culturally sensitive guidelines that include limitations and oversight procedures to ensure that science responds to societal needs and values.
Kirstin R.W. Matthews, Ana S. Iltis, Sam Lowe December 21, 2021
Blue stem cell under microscope
Unproven Stem Cell Interventions: A Global Public Health Problem Requiring Global Deliberation
The unproven stem cell intervention industry is a worldwide, direct-to-consumer market where clinics offer stem cells or stem cell-derived components to patients with little to no scientific or clinical basis. In this paper, the authors call for the establishment of a World Health Organization Expert Advisory Committee on Regenerative Medicine to tackle this issue and provide guidance. Stem Cell Reports: https://doi.org/10.1016/j.stemcr.2021.05.004
Kirstin R.W. Matthews, Zubin Master, Mohamed Abou-el-Enein June 9, 2021
A needle poking a human cell.
Rethinking Human Embryo Research Policies
It now seems technically feasible to culture human embryos beyond the “fourteen‐day limit,” which has the potential to increase scientific understanding of human development and perhaps improve infertility treatments. Robust stakeholder engagement preceded adoption of the fourteen‐day limit and should arguably be part of efforts to reassess it, write the authors.
Kirstin R.W. Matthews, Ana S. Iltis, Daniel S. Wagner, Nuria Gallego Marquez, Jason Scott Robert, Inmaculada de Melo-Martín, Marieke Bigg, Sarah Franklin, Soren Holm, Ingrid Metzler, Matteo A. Molè, Jochen Taupitz, Giuseppe Testa, Jeremy Sugarman February 26, 2021